Exelixis Inc. buy Brookline Capital Management
Start price
23.12.24
/
50%
€31.85
Target price
23.12.25
-
Performance (%)
24.87%
End price
24.12.25
€39.77
Summary
This prediction ended on 24.12.25 with a price of €39.77. The prediction had a final performance of 24.87%. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -6.836% | -6.836% | 9.236% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) is now covered by analysts at Brookline Capital Management. They set a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten